Vol. 3Sanqing Goes Global
Wei Kang expanded Sanqing’s medicines, gene-editing work, and agricultural products while overcoming patent disputes and building international partnerships. After growing Sanqing’s formula collection to more than two thousand prescriptions, he used the system’s drawing function and won a blueprint for an electronic product.
- Wei Kang responded to Illumina’s sequencer cutoff by testing domestic machines and expanding Sanqing’s drug projects, while its scar-removal cream became a major success.
- Sanqing’s scar-removal cream sold out, and reports revealed that locusts had returned to Feizhou in overwhelming numbers.
- Xia Lizhi and foreign officials used Sanqing’s pesticide to kill locusts, bringing the company major international orders.
- Sanqing developed a Thalassemia Gene Drug for Salman and advanced Super Soybean trials, with one variety yielding more than 1,000 jin per mu.
- Wei Kang and Tang Que developed a new gene-editing technology as Sanqing faced patent lawsuits and a halt to its Eagle Country sales, before the Broad Institute withdrew its suit.
- Wang De arranged Super Soybean deals abroad, while Zhang Chunming shifted Sanqing’s Feizhou medicine strategy toward local partnerships and aid.
- Wei Kang expanded Three Purities’ overseas charity and launched safer cardiovascular drugs as Sanofi recalled contaminated Irbesartan and Sanqing’s business grew.
- Wei Kang acquired abandoned drug formulas, collected more than two thousand prescriptions, and won an electronic-product blueprint through system draws.